Eccogene
Clinical trials sponsored by Eccogene, explained in plain language.
-
New drug combo aims to melt liver fat in MASH patients
Disease control Recruiting nowThis study tests two experimental drugs, ECC4703 and ECC0509, alone or together, to see if they can reduce fat buildup in the liver of people with MASH (a serious fatty liver disease). About 160 adults with MASH will take the drugs or a placebo for 12 weeks. The main goal is to m…
Phase: PHASE2 • Sponsor: Eccogene • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Healthy volunteers test new liver drug with breakfast
Knowledge-focused Recruiting nowThis early-stage study tests a new drug called ECC4703 in 72 healthy adults. The goal is to see if taking the drug with food changes how the body absorbs it. Participants will receive a single dose of the drug in different forms, and researchers will measure drug levels in the bl…
Phase: PHASE1 • Sponsor: Eccogene • Aim: Knowledge-focused
Last updated May 19, 2026 12:00 UTC